• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    TearLab Corporation (TEAR)

    -NasdaqCM
    1.98 Down 0.15(7.04%) Jan 23, 4:00PM EST
    Add to Portfolio
    Prev Close:2.13
    Open:2.12
    Bid:N/A
    Ask:9.63 x 800
    1y Target Est:4.60
    Beta:4.07
    Next Earnings Date:N/A
    Day's Range:1.95 - 2.12
    52wk Range:1.95 - 8.46
    Volume:322,808
    Avg Vol (3m):213,221
    Market Cap:66.50M
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    TEARDown 7.04%66.50M
    ABTDown 1.42%66.04B
    NVDQUp 0.71%792.57M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.67
    Quarterly EPS Est (Dec-14) :-0.17
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):-0.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback